Robotic surgery in obese patients with early-stage endometrial cancer

AIM: The objective of this study was to assess the clinical effectiveness of robotic surgery for obese patients (body mass index (BMI) ≥ 30 kg/m(2)) with early stage endometrial cancer. MATERIAL AND METHODS: This study is a retrospective review of women who underwent robotic surgery for early-stage endometrial cancer from 2008 to 2017. Patients were subdivided into those with BMI < 30 kg/m(2) (group 1), and those with BMI ≥ 30 kg/m(2) (group 2). Basic demographics and perioperative period outcomes were extracted from the medical records and compared. RESULTS: Group 1 included fifty patients and group 2 included 24 patients. There were no significant differences in surgical outcomes or complication rates between the two groups (p > 0.05 for all). There were no differences in pelvic nodal counts or length of stay. CONCLUSIONS: Robotic surgery was found to be feasible and safe for obese patients with endometrial cancer. Its widespread application needs a larger sample with longer follow-up.